Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., (2015) 473 F.T.R. 1 (FC)
Linked as:
Extract
Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC et al., (2015) 473 F.T.R. 1 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FC 320
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
- Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
- Fournier Pharma Inc. et al. v. Canada (Minister of Health) et al., (2012) 413 F.T.R. 277 (FC)